CytomX (CTMX) director Su Zhen awarded 59,000 stock options at $2.96
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CytomX Therapeutics director Su Zhen received a grant of stock options covering 59,000 shares of common stock. The options were awarded at an exercise price of $2.96 per share and are held directly. Following this grant, Su Zhen holds stock options for 59,000 shares.
According to the vesting terms, all 59,000 option shares will vest in full on the earlier of the first anniversary of the grant date or the date of CytomX’s 2027 annual stockholder meeting, assuming continuous service as a director through that vesting date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Su Zhen
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 59,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 59,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 59,000 options
Exercise price: $2.96 per share
Underlying shares: 59,000 shares
+2 more
5 metrics
Options granted
59,000 options
Stock Option (Right to Buy) grant to Su Zhen
Exercise price
$2.96 per share
Strike price for Su Zhen’s 59,000 options
Underlying shares
59,000 shares
Common stock underlying the option grant
Post-grant options held
59,000 options
Total options held following this transaction
Expiration date
June 16, 2036
Option expiration for Su Zhen’s grant
Key Terms
Stock Option (Right to Buy), exercise price, derivative securities, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" on the derivative line"
exercise price financial
"conversion_or_exercise_price: "2.9600" as the exercise price per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
derivative securities financial
"transaction_type: "derivative" describing the option grant transaction"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
vesting financial
"100% of the shares subject to the option shall vest in full"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
continuous service financial
"assuming continuous service as a director until such vesting date"
FAQ
What did CytomX Therapeutics (CTMX) director Su Zhen report on this Form 4?
The Form 4 reports that director Su Zhen received a grant of stock options for 59,000 shares of CytomX common stock. These options are a compensation-related award and are not an open-market purchase or sale of existing shares.
How many CytomX (CTMX) stock options did Su Zhen receive and at what price?
Su Zhen received stock options covering 59,000 shares of CytomX common stock with an exercise price of $2.96 per share. This means Su Zhen can buy up to 59,000 shares at $2.96 once the options are vested and exercisable.
When do Su Zhen’s CytomX (CTMX) stock options vest?
All 59,000 option shares will vest in full on the earlier of the first anniversary of the grant date or the date of CytomX’s 2027 annual stockholder meeting. Vesting requires Su Zhen to remain in continuous service as a director until that date.
How many CytomX (CTMX) options does Su Zhen hold after this transaction?
After the reported grant, Su Zhen holds stock options for 59,000 shares of CytomX common stock. This figure reflects the total derivative securities for this option award shown in the filing’s post-transaction holdings field.
What type of security is involved in Su Zhen’s CytomX (CTMX) Form 4?
The security involved is a “Stock Option (Right to Buy)” with an underlying security of CytomX common stock. Each option gives the right to purchase one share at $2.96, subject to the vesting schedule described in the filing’s footnote.